Stock AKYA AKOYA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/05/2024 BST 		5-day change 1st Jan Change
4.12 USD -3.40% Intraday chart for Akoya Biosciences, Inc. 0.00% -15.57%
09:46am Akoya Biosciences Sinks Over 30% in Late-Hours Activity Monday as Q1 Sales Miss Capital IQ Estimate MT
05-13 Transcript : Akoya Biosciences, Inc., Q1 2024 Earnings Call, May 13, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Akoya: Q1 Earnings Snapshot
AQ
Akoya Biosciences Reports First Quarter 2024 Financial Results
GL
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
GL
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
AQ
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
GL
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
AQ
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
GL
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
GL
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
GL
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
AQ
Akoya: Q4 Earnings Snapshot
AQ
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
GL
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
AQ
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
GL
Akoya Biosciences Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
AQ
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
GL
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
AQ
Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
GL
Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
AQ
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AKYA Stock
  4. News Akoya Biosciences, Inc.
  5. Press Releases